FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SCUBE2-DENND5A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SCUBE2-DENND5A
FusionPDB ID: 79753
FusionGDB2.0 ID: 79753
HgeneTgene
Gene symbol

SCUBE2

DENND5A

Gene ID

57758

23258

Gene namesignal peptide, CUB domain and EGF like domain containing 2DENN domain containing 5A
SynonymsCEGB1|CEGF1|CEGP1|scube/YouEIEE49|RAB6IP1
Cytomap

11p15.4

11p15.4

Type of geneprotein-codingprotein-coding
Descriptionsignal peptide, CUB and EGF-like domain-containing protein 2DENN domain-containing protein 5ADENN/MADD domain containing 5ARAB6 interacting protein 1rab6-interacting protein 1
Modification date2020031320200313
UniProtAcc.

Q6IQ26

Main function of 5'-partner protein: FUNCTION: Guanine nucleotide exchange factor (GEF) which may activate RAB6A and RAB39A and/or RAB39B. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. Involved in the negative regulation of neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:G3V7Q0, ECO:0000269|PubMed:20937701}.
Ensembl transtripts involved in fusion geneENST idsENST00000309263, ENST00000450649, 
ENST00000457346, ENST00000520467, 
ENST00000534295, 
ENST00000527700, 
ENST00000526523, ENST00000328194, 
ENST00000530044, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 6 X 4=14415 X 15 X 6=1350
# samples 616
** MAII scorelog2(6/144*10)=-1.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(16/1350*10)=-3.07681559705083
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SCUBE2 [Title/Abstract] AND DENND5A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SCUBE2 [Title/Abstract] AND DENND5A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DENND5A(9286508)-SCUBE2(9144441), # samples:2
DENND5A(9171628)-SCUBE2(9043502), # samples:2
SCUBE2(9087438)-DENND5A(9192324), # samples:1
Anticipated loss of major functional domain due to fusion event.SCUBE2-DENND5A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SCUBE2-DENND5A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SCUBE2-DENND5A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SCUBE2-DENND5A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DENND5A-SCUBE2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
DENND5A-SCUBE2 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:9286508/chr11:9144441)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SCUBE2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across DENND5A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000457346SCUBE2chr119087438-ENST00000328194DENND5Achr119192324-3729925512882943
ENST00000457346SCUBE2chr119087438-ENST00000530044DENND5Achr119192324-3061925512744897
ENST00000309263SCUBE2chr119087438-ENST00000328194DENND5Achr119192324-3727923492880943
ENST00000309263SCUBE2chr119087438-ENST00000530044DENND5Achr119192324-3059923492742897
ENST00000450649SCUBE2chr119087438-ENST00000328194DENND5Achr119192324-3672868182825935
ENST00000450649SCUBE2chr119087438-ENST00000530044DENND5Achr119192324-3004868182687889
ENST00000520467SCUBE2chr119087438-ENST00000328194DENND5Achr119192324-3725921472878943
ENST00000520467SCUBE2chr119087438-ENST00000530044DENND5Achr119192324-3057921472740897

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000457346ENST00000328194SCUBE2chr119087438-DENND5Achr119192324-0.0024215330.99757844
ENST00000457346ENST00000530044SCUBE2chr119087438-DENND5Achr119192324-0.0069302850.9930697
ENST00000309263ENST00000328194SCUBE2chr119087438-DENND5Achr119192324-0.0024281130.9975719
ENST00000309263ENST00000530044SCUBE2chr119087438-DENND5Achr119192324-0.0069432860.99305665
ENST00000450649ENST00000328194SCUBE2chr119087438-DENND5Achr119192324-0.0023385560.9976615
ENST00000450649ENST00000530044SCUBE2chr119087438-DENND5Achr119192324-0.0070542530.99294573
ENST00000520467ENST00000328194SCUBE2chr119087438-DENND5Achr119192324-0.0024540140.997546
ENST00000520467ENST00000530044SCUBE2chr119087438-DENND5Achr119192324-0.006985040.99301493

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SCUBE2-DENND5A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SCUBE2chr119087438DENND5Achr119192324868283VDGDKRVKRRLLMEKAIELRLAKIDH
SCUBE2chr119087438DENND5Achr119192324921291VDGDKRVKRRLLMEKAIELRLAKIDH
SCUBE2chr119087438DENND5Achr119192324923291VDGDKRVKRRLLMEKAIELRLAKIDH
SCUBE2chr119087438DENND5Achr119192324925291VDGDKRVKRRLLMEKAIELRLAKIDH

Top

Potential FusionNeoAntigen Information of SCUBE2-DENND5A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SCUBE2-DENND5A_9087438_9192324.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:05RRLLMEKAI0.99970.7146817
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:04RRLLMEKAI0.99960.6716817
SCUBE2-DENND5Achr119087438chr119192324923HLA-B08:01LLMEKAIEL0.99490.79661019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B08:09LLMEKAIEL0.99250.72471019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B13:01MEKAIELRL0.99230.84561221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B14:01LLMEKAIEL0.9780.711019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B14:02LLMEKAIEL0.9780.711019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B44:03MEKAIELRL0.97780.95511221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:01MEKAIELRL0.96250.78691221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B13:01LLMEKAIEL0.39090.91911019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:13MEKAIELRL0.32420.9141221
SCUBE2-DENND5Achr119087438chr119192324923HLA-A30:08RVKRRLLMEK0.99840.7661515
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:22RLLMEKAIEL0.99830.5107919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:11RLLMEKAIEL0.99690.5024919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:04RLLMEKAIEL0.99610.5486919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:27RLLMEKAIEL0.99540.5331919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:13RLLMEKAIEL0.99490.6346919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:38RLLMEKAIEL0.98850.6287919
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:35RLLMEKAIEL0.92980.5052919
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:05RRLLMEKAIEL10.7497819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:04RRLLMEKAIEL10.7018819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A74:11RLLMEKAIELR0.99480.5172920
SCUBE2-DENND5Achr119087438chr119192324923HLA-A74:03RLLMEKAIELR0.99480.5172920
SCUBE2-DENND5Achr119087438chr119192324923HLA-A74:09RLLMEKAIELR0.99480.5172920
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:04RRLLMEKAIEL0.97950.5844819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:11RRLLMEKAIEL0.97780.5146819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:24RRLLMEKAIEL0.97680.5003819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:67RRLLMEKAIEL0.97680.5003819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:30RRLLMEKAIEL0.97680.5003819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:22RRLLMEKAIEL0.97660.5104819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:60RRLLMEKAIEL0.97650.5008819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:20RRLLMEKAIEL0.97550.501819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:35RRLLMEKAIEL0.9720.5345819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:27RRLLMEKAIEL0.97190.5663819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:13RRLLMEKAIEL0.96260.7165819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:14RRLLMEKAI0.99970.6363817
SCUBE2-DENND5Achr119087438chr119192324923HLA-C05:09LLMEKAIEL0.99940.91211019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:10LLMEKAIEL0.99920.77881019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:07LLMEKAIEL0.99910.781019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:07LLMEKAIEL0.99910.97891019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B42:02LLMEKAIEL0.99810.77691019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C15:06LLMEKAIEL0.99810.89651019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B40:06MEKAIELRL0.99810.52251221
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:19LLMEKAIEL0.99770.98581019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:14KRRLLMEKA0.99670.7437716
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:08LLMEKAIEL0.99620.88781019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:06LLMEKAIEL0.99570.80911019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:14LLMEKAIEL0.99560.76781019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C01:17LLMEKAIEL0.99410.94711019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:03RRLLMEKAI0.99040.7477817
SCUBE2-DENND5Achr119087438chr119192324923HLA-C08:13LLMEKAIEL0.98890.95861019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C08:04LLMEKAIEL0.98890.95861019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B15:04LLMEKAIEL0.98410.92531019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C02:06LLMEKAIEL0.98050.96891019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C01:30LLMEKAIEL0.97970.95091019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:14LLMEKAIEL0.96560.9751019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C08:03LLMEKAIEL0.96550.981019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:13LLMEKAIEL0.95880.9181019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:29LLMEKAIEL0.9410.90481019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B14:03LLMEKAIEL0.91850.63851019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:67LLMEKAIEL0.91730.9521019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:80LLMEKAIEL0.91730.9521019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:10LLMEKAIEL0.89860.96171019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:05LLMEKAIEL0.87620.95541019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:27LLMEKAIEL0.81120.95381019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:10LLMEKAIEL0.59440.88051019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:08MEKAIELRL0.58720.82541221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:12LLMEKAIEL0.56580.90151019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:14RRLLMEKAIEL10.7185819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:03RRLLMEKAIEL0.99980.7769819
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:01RRLLMEKAIEL0.97680.5003819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:08RRLLMEKAI0.99970.623817
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:10RRLLMEKAI0.99960.8478817
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:06RRLLMEKAI0.99950.6778817
SCUBE2-DENND5Achr119087438chr119192324923HLA-C05:01LLMEKAIEL0.99940.91211019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:03LLMEKAIEL0.99940.80991019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:09RRLLMEKAI0.99920.7292817
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:01LLMEKAIEL0.99910.781019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B40:04MEKAIELRL0.99840.70681221
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:03LLMEKAIEL0.99820.98191019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:04LLMEKAIEL0.99820.98191019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C15:05LLMEKAIEL0.99780.88891019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C18:01LLMEKAIEL0.99780.80031019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C01:03LLMEKAIEL0.99750.92081019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C06:06LLMEKAIEL0.99680.98461019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:67LLMEKAIEL0.99550.96761019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:17LLMEKAIEL0.99550.95921019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C01:02LLMEKAIEL0.9950.94431019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C04:04LLMEKAIEL0.9950.79161019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B08:18LLMEKAIEL0.99490.79661019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B15:73LLMEKAIEL0.9940.78341019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:05LLMEKAIEL0.99330.90011019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C03:06LLMEKAIEL0.99240.98341019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:04LLMEKAIEL0.98320.9051019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B08:12LLMEKAIEL0.97960.87461019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B44:13MEKAIELRL0.97780.95511221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B44:07MEKAIELRL0.97780.95511221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B44:26MEKAIELRL0.97780.95511221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B15:30LLMEKAIEL0.97590.76221019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:04MEKAIELRL0.96910.80641221
SCUBE2-DENND5Achr119087438chr119192324923HLA-C08:01LLMEKAIEL0.96550.981019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:05MEKAIELRL0.96250.78691221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:08MEKAIELRL0.95730.73661221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:06MEKAIELRL0.95390.79191221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:03MEKAIELRL0.94140.76971221
SCUBE2-DENND5Achr119087438chr119192324923HLA-C17:01LLMEKAIEL0.93250.91241019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:02LLMEKAIEL0.91730.9521019
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:17LLMEKAIEL0.85050.96541019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B35:13LLMEKAIEL0.80660.89491019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B18:11MEKAIELRL0.69610.82571221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B07:13LLMEKAIEL0.6860.81571019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:02LLMEKAIEL0.60560.88991019
SCUBE2-DENND5Achr119087438chr119192324923HLA-B41:03MEKAIELRL0.56170.56471221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B39:02MEKAIELRL0.43450.91661221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B48:02MEKAIELRL0.33320.92851221
SCUBE2-DENND5Achr119087438chr119192324923HLA-B15:53MEKAIELRL0.14870.77241221
SCUBE2-DENND5Achr119087438chr119192324923HLA-A30:01RVKRRLLMEK0.99840.8962515
SCUBE2-DENND5Achr119087438chr119192324923HLA-A02:03RLLMEKAIEL0.99790.6063919
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:08RRLLMEKAIEL10.6785819
SCUBE2-DENND5Achr119087438chr119192324923HLA-C07:01RRLLMEKAIEL10.64819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:10RRLLMEKAIEL10.8493819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:06RRLLMEKAIEL10.717819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:09RRLLMEKAIEL10.7544819
SCUBE2-DENND5Achr119087438chr119192324923HLA-B27:10KRVKRRLLMEK0.99970.9269415
SCUBE2-DENND5Achr119087438chr119192324923HLA-A74:01RLLMEKAIELR0.99480.5172920

Top

Potential FusionNeoAntigen Information of SCUBE2-DENND5A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SCUBE2-DENND5A_9087438_9192324.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0101KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0101VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0102KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0102VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0102RVKRRLLMEKAIELR520
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0103KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0105KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0105VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0107KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0107VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0109KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0109VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0111KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0111VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0111RVKRRLLMEKAIELR520
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0113KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0115KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0115VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0117KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0119KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0119VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0121KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0123KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0123VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0123RVKRRLLMEKAIELR520
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0125KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0125VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0127KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0127VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0129KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0129VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0131KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-0131VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-1222KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-1525KRRLLMEKAIELRLA722
SCUBE2-DENND5Achr119087438chr119192324923DRB1-1525VKRRLLMEKAIELRL621
SCUBE2-DENND5Achr119087438chr119192324923DRB1-1525RVKRRLLMEKAIELR520
SCUBE2-DENND5Achr119087438chr119192324923DRB1-1615KRRLLMEKAIELRLA722

Top

Fusion breakpoint peptide structures of SCUBE2-DENND5A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10047VKRRLLMEKAIELRSCUBE2DENND5Achr119087438chr119192324923

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SCUBE2-DENND5A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10047VKRRLLMEKAIELR-7.15543-7.26883
HLA-B14:023BVN10047VKRRLLMEKAIELR-4.77435-5.80965
HLA-B52:013W3910047VKRRLLMEKAIELR-6.80875-6.92215
HLA-B52:013W3910047VKRRLLMEKAIELR-4.20386-5.23916
HLA-A11:014UQ210047VKRRLLMEKAIELR-7.5194-8.5547
HLA-A11:014UQ210047VKRRLLMEKAIELR-6.9601-7.0735
HLA-A24:025HGA10047VKRRLLMEKAIELR-7.52403-7.63743
HLA-A24:025HGA10047VKRRLLMEKAIELR-5.82433-6.85963
HLA-B27:056PYJ10047VKRRLLMEKAIELR-3.28285-4.31815
HLA-B44:053DX810047VKRRLLMEKAIELR-5.91172-6.94702
HLA-B44:053DX810047VKRRLLMEKAIELR-4.24346-4.35686
HLA-B35:011A1N10047VKRRLLMEKAIELR-5.9251-6.0385
HLA-B35:011A1N10047VKRRLLMEKAIELR-4.80237-5.83767

Top

Vaccine Design for the FusionNeoAntigens of SCUBE2-DENND5A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SCUBE2-DENND5Achr119087438chr1191923241019LLMEKAIELTGCTCATGGAGAAAGCAATTGAGCTGC
SCUBE2-DENND5Achr119087438chr1191923241221MEKAIELRLTGGAGAAAGCAATTGAGCTGCGTCTGG
SCUBE2-DENND5Achr119087438chr119192324415KRVKRRLLMEKAACGGGTGAAACGGCGGCTGCTCATGGAGAAAG
SCUBE2-DENND5Achr119087438chr119192324515RVKRRLLMEKGGGTGAAACGGCGGCTGCTCATGGAGAAAG
SCUBE2-DENND5Achr119087438chr119192324716KRRLLMEKAAACGGCGGCTGCTCATGGAGAAAGCAA
SCUBE2-DENND5Achr119087438chr119192324817RRLLMEKAIGGCGGCTGCTCATGGAGAAAGCAATTG
SCUBE2-DENND5Achr119087438chr119192324819RRLLMEKAIELGGCGGCTGCTCATGGAGAAAGCAATTGAGCTGC
SCUBE2-DENND5Achr119087438chr119192324919RLLMEKAIELGGCTGCTCATGGAGAAAGCAATTGAGCTGC
SCUBE2-DENND5Achr119087438chr119192324920RLLMEKAIELRGGCTGCTCATGGAGAAAGCAATTGAGCTGCGTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SCUBE2-DENND5Achr119087438chr119192324520RVKRRLLMEKAIELRGGGTGAAACGGCGGCTGCTCATGGAGAAAGCAATTGAGCTGCGTC
SCUBE2-DENND5Achr119087438chr119192324621VKRRLLMEKAIELRLTGAAACGGCGGCTGCTCATGGAGAAAGCAATTGAGCTGCGTCTGG
SCUBE2-DENND5Achr119087438chr119192324722KRRLLMEKAIELRLAAACGGCGGCTGCTCATGGAGAAAGCAATTGAGCTGCGTCTGGCAA

Top

Information of the samples that have these potential fusion neoantigens of SCUBE2-DENND5A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCASCUBE2-DENND5Achr119087438ENST00000309263chr119192324ENST00000328194TCGA-D8-A27R-01A

Top

Potential target of CAR-T therapy development for SCUBE2-DENND5A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SCUBE2-DENND5A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SCUBE2-DENND5A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource